Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Aluminum vaccine adjuvants: are they safe?

Tomljenovic L, Shaw CA.

Curr Med Chem. 2011;18(17):2630-7.

PMID:
21568886
2.

Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations.

Tomljenovic L, Shaw CA.

Lupus. 2012 Feb;21(2):223-30. doi: 10.1177/0961203311430221.

PMID:
22235057
3.

[Aluminum as an adjuvant in vaccines and post-vaccine reactions].

Fiejka M, Aleksandrowicz J.

Rocz Panstw Zakl Hig. 1993;44(1):73-80. Review. Polish.

PMID:
8235346
4.

Aluminum toxicokinetics regarding infant diet and vaccinations.

Keith LS, Jones DE, Chou CH.

Vaccine. 2002 May 31;20 Suppl 3:S13-7. Review.

PMID:
12184359
5.

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

Shaw CA, Li D, Tomljenovic L.

Immunotherapy. 2014;6(10):1055-71. doi: 10.2217/imt.14.81. Review.

PMID:
25428645
6.

Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.

Mitkus RJ, King DB, Hess MA, Forshee RA, Walderhaug MO.

Vaccine. 2011 Nov 28;29(51):9538-43. doi: 10.1016/j.vaccine.2011.09.124.

PMID:
22001122
7.
8.

Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.

Kuroda Y, Nacionales DC, Akaogi J, Reeves WH, Satoh M.

Biomed Pharmacother. 2004 Jun;58(5):325-37. Review.

PMID:
15194169
9.

The global impact of vaccines containing aluminium adjuvants.

Clements CJ, Griffiths E.

Vaccine. 2002 May 31;20 Suppl 3:S24-33. Review.

PMID:
12184361
10.

Vaccine adjuvants.

Macy DW.

Semin Vet Med Surg (Small Anim). 1997 Aug;12(3):206-11. Review.

PMID:
9283246
11.

Adjuvants for human vaccines--current status, problems and future prospects.

Gupta RK, Siber GR.

Vaccine. 1995 Oct;13(14):1263-76. Review.

PMID:
8585280
12.
13.

Adjuvants and autoimmunity.

Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y.

Lupus. 2009 Nov;18(13):1217-25. doi: 10.1177/0961203309345724. Review.

PMID:
19880572
14.

Public health. Aluminum is put on trial as a vaccine booster.

Malakoff D.

Science. 2000 May 26;288(5470):1323-4. No abstract available.

PMID:
10847840
15.

[Adverse reactions to vaccines].

Eseverri JL, Ranea S, Marin A.

Allergol Immunopathol (Madr). 2003 May-Jun;31(3):125-38. Review. Spanish.

PMID:
12783762
16.

Itching nodules and hypersensitivity to aluminium after the use of adsorbed vaccines from SSI.

Thierry-Carstensen B, Stellfeld M.

Vaccine. 2004 May 7;22(15-16):1845. No abstract available.

PMID:
15121293
17.

Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.

Berthold I, Pombo ML, Wagner L, Arciniega JL.

Vaccine. 2005 Mar 14;23(16):1993-9.

PMID:
15734073
18.

Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants.

Jendrek S, Little SF, Hem S, Mitra G, Giardina S.

Vaccine. 2003 Jun 20;21(21-22):3011-8.

PMID:
12798645
19.
20.

Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?

Tomljenovic L, Shaw CA.

J Inorg Biochem. 2011 Nov;105(11):1489-99. doi: 10.1016/j.jinorgbio.2011.08.008.

PMID:
22099159
Items per page

Supplemental Content

Support Center